Fuquan Capital Management, Inc.

Fuquan Capital Management, Inc., based in Malvern, Pennsylvania, is dedicated to developing and commercializing nutritional and various other products sourced from algae. The company's diverse range includes algae-based biomass for human, piscine, and animal diets, alongside algae cakes specifically formulated for livestock and aquaculture. The company also manufactures astaxanthin, a compound utilized for alleviating joint discomfort and managing muscular degeneration, and omega-3, recognized for its efficacy in preventing heart conditions and cancer, as well as enhancing immune function. Beyond dietary applications, their portfolio encompasses algae oils for biofuel generation, bio-oil, and bio-plastic production, alongside solutions for carbon sequestration. Additionally, the company offers nutraceuticals and natural remedies for disease prevention and treatment, notably spirulina, which serves as a crucial nutrient and protein supplement for human consumption and addressing malnutrition. The firm further provides sports medicine equipment engineered to boost mobility and balance, diminish joint pain, sculpt muscle, and aid in weight reduction. The company serves clients across the nutraceutical, pharmaceutical, and general health and wellness sectors. Formerly known as International Sustainability Group, Inc., the company has operated as a subsidiary of Fuquan Capital Corporation, Inc. since September 28, 2017, and adopted its current name thereafter.